Serenity Pharmaceuticals LLC gained FDA approval of its urology drug Noctiva (desmopressin acetate) as the first approved drug therapy for nocturia due to nocturnal polyuria, but it lost Allergan PLC as a marketing partner.
The US FDA approved Noctiva nasal spray March 3, but with a boxed warning and a narrower indication than Milford,...





